Stoke Therapeutics Inc (STOK)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: PHARMACEUTICAL PREPARATIONS

3 PRESTON COURT BEDFORD, MA 01730

Stoke Therapeutics, Inc. operates as a biotechnology company. The Company develops antisense oligonucleotide medicines and therapies that increase target gene expression to treat diseases caused by loss of protein function. Stoke Therapeutics serves patients and customers in the United States.

View SEC Filings from STOK instead.
Q2 2019 All Institutions Hedge Funds 1
To trade STOK now:
Filers who had this stock in their top 10: 2 2 (0.21%)
13F Filers holding this stock: 47 22 (2.27%)
Aggregate 13F shares on 06/30/2019: 14.208 Million 9.432 Million
Aggregate 13F shares on 03/31/2019: 0
Percent change:
Funds creating new positions: 46 22
Funds Adding to an existing position:
Funds closing out their position:
Funds reducing their position:
1 hedge funds as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding STOK (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

31.6 Thousand total shares from 1 transactions

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

RTW INVESTMENTS, LP

WONG RODERICK

  • 10% Owner
3,535,493 2019-10-10 3

REDMILE GROUP, LLC

GREEN JEREMY

  • 10% Owner
2,268,718 2019-10-07 2

TZIANABOS ARTHUR PRESIDENT & CEO

  • Officer
  • Director
127,505 2019-10-01 2

LEVIN ARTHUR A

  • Director
0 2019-09-10 2

HARRISON SETH LORING

  • Director
  • 10% Owner
0 2019-09-10 3

KRAINER ADRIAN R.

  • Director
0 2019-09-10 2

HALL SAMUEL W.

  • Director
  • 10% Owner
0 2019-09-10 2

BURSTEIN JENNIFER

  • Director
0 2019-09-10 2

APPLE TREE PARTNERS IV, L.P.

ATP III GP, LTD.

  • 10% Owner
5,415,203 2019-06-24 1

TULIPANO STEPHEN J CHIEF FINANCIAL OFFICER

  • Officer
0 2019-06-18 1

KAYE EDWARD M. MD CEO

  • Officer
  • Director
0 2019-06-18 1

TICHO BARRY CHIEF MEDICAL OFFICER

  • Officer
0 2019-06-18 1

LIAU GENE EVP, HEAD OF RESEARCH

  • Officer
0 2019-06-18 1

NASH HUW M. COO & CBO

  • Officer
0 2019-06-18 1

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5

RTW INVESTMENTS, LP - > 10% Owner by rtw

WONG RODERICK - > 10% Owner by rtw

2019-10-01 P 31,560 $21.96 a 3,387,026 3,387,026.00 indirect

HARRISON SETH LORING - Director - > 10% Owner

2019-09-10 A 29,555 a 29,555 0.00 direct

KRAINER ADRIAN R. - Director

2019-09-10 A 14,777 a 14,777 0.00 direct

BURSTEIN JENNIFER - Director

2019-09-10 A 29,555 a 29,555 0.00 direct

LEVIN ARTHUR A - Director

2019-09-10 A 14,777 a 14,777 0.00 direct

HALL SAMUEL W. - Director - > 10% Owner

2019-09-10 A 29,555 a 29,555 0.00 direct

TZIANABOS ARTHUR - Director

2019-09-10 A 14,777 a 14,777 0.00 direct
Click here to report any possible errors with this stock listing.

Elevate your investments